Transient and permanent deafness following treatment with ethacrynic acid in renal failure.
D000328:Adult; D000661:Amphetamine / Q000506:poisoning; D001022:Aortic Valve Insufficiency / Q000150:complications; D001219:Aspartate Aminotransferases / Q000097:blood; D001806:Blood Urea Nitrogen; D002252:Carbon Tetrachloride Poisoning; D006332:Cardiomegaly / Q000150:complications; D003404:Creatinine / Q000097:blood; D003638:Deafness / Q000139:chemically induced*; D004976:Ethacrynic Acid / Q000009:adverse effects*; D005260:Female; D006400:Hematocrit; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D006435:Renal Dialysis; D014511:Uremia / Q000188:drug therapy / Q000628:therapy; D001748:Urinary Bladder Neck Obstruction / Q000150:complications
D003404:Creatinine; D000661:Amphetamine; D001219:Aspartate Aminotransferases; D004976:Ethacrynic Acid